Chester County News and Community Website
Teleflex Incorporated (NYSE: TFX), headquartered in Wayne, PA, is a global provider of medical technologies designed to improve the health and quality of people’s lives, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care.
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has shared promising preliminary results from its Ringer™ PBC IDE study, featured in a presentation at the CTO Plus Conference in New York. The …
Teleflex Reports Promising Preliminary Results for Ringer PBC Study Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has unveiled groundbreaking results from the CLEAR study, the first head-to-head randomized controlled trial comparing the UroLift™ System with Rezūm™ Water Vapor Therapy (WVTT) …
Study Highlights UroLift™ System’s Advantages Over Rezūm™ in Treating BPH Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has reported its financial results for the fourth quarter and full year ended December 31, 2024, alongside key strategic announcements for 2025, including a …
Teleflex Reports 2024 Financial Results, Reveals Strategic Initiatives for 2025 Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has announced the retirement of Thomas E. Powell, its long-serving Executive Vice President and Chief Financial Officer, effective April 1, 2025. After more than …
Teleflex Announces Leadership Transition as CFO Thomas E. Powell Retires Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has announced plans to separate its Urology, Acute Care, and OEM businesses into a standalone, publicly traded company, “NewCo.” The decision, approved by the …
Teleflex to Spin Off Urology, Acute Care, and OEM Businesses into Independent Company Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has announced its agreement to acquire BIOTRONIK’s Vascular Intervention business in a transaction valued at approximately €760 million. With this strategic acquisition, Teleflex aims …
Teleflex Acquires BIOTRONIK’s Vascular Intervention Business in $760 Million Deal Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) is scheduled to present at the Raymond James & Associates 46th Annual Institutional Investors Conference. The presentation will take place at the JW …
Teleflex to Present at Raymond James 46th Annual Investor Conference Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has announced a new contract with Vizient, Inc., the nation’s largest healthcare performance improvement company. Effective January 1, 2025, the agreement grants Vizient’s members …
Teleflex Secures Contract with Vizient to Supply Vascular Access Products Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has released its financial results for the third quarter ending September 29, 2024, showing a 2.4% increase in GAAP revenue to $764.4 million compared …
Teleflex Reports Third-Quarter Growth and Strategic Advancements Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has announced the enrollment of the first patient in a new clinical study focused on the Barrigel™ rectal spacer. This major milestone marks …
Teleflex Inc. Enrolls First Patient in Barrigel™ Rectal Spacer Study Read More